ARIEL3: A phase 3, randomized, double-blind study of rucaparib vs placebo following response to platinum-based chemotherapy for recurrent ovarian cancer (OC) Meeting Abstract


Authors: Coleman, R. L.; Oza, A. M.; Lorusso, D.; Aghajanian, C.; Oaknin, A.; Dean, A.; Colombo, N.; Weberpals, J. I.; Clamp, A.; Scambia, G.; Leary, A.; Holloway, R. W.; O'Malley, D. M.; Cameron, T.; Maloney, L.; Goble, S.; Lin, K.; Sun, J.; Giordano, H.; Ledermann, J. A.
Abstract Title: ARIEL3: A phase 3, randomized, double-blind study of rucaparib vs placebo following response to platinum-based chemotherapy for recurrent ovarian cancer (OC)
Meeting Title: AACR Special Conference: Addressing Critical Questions in Ovarian Cancer Research and Treatment
Journal Title: Clinical Cancer Research
Volume: 24
Issue: 15 Suppl.
Meeting Dates: 2017 Oct 1-4
Meeting Location: Pittsburgh, PA
ISSN: 1078-0432
Publisher: American Association for Cancer Research  
Date Published: 2018-08-01
Start Page: 30
End Page: 31
Language: English
ACCESSION: WOS:000440823600029
PROVIDER: wos
DOI: 10.1158/1557-3265.OVCA17-PR06
Notes: Meeting Abstract: PR06 -- Source: Wos
Altmetric Score
MSK Authors